This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| SARS | 1451 |
| PCR | 551 |
| HCoV | 548 |
| CoV-2 | 542 |
| CoV | 537 |
| RNA | 368 |
| MERS | 367 |
| RSV | 340 |
| COVID-19 | 319 |
| OC43 | 298 |
| A | 259 |
| RT | 238 |
| C | 211 |
| S | 210 |
| H1N1 | 208 |
| T | 205 |
| HRV | 205 |
| Health | 184 |
| HBoV | 184 |
| NL63 | 183 |
| J | 165 |
| CD4 | 162 |
| M | 162 |
| Table | 157 |
| China | 156 |
| A(H1N1)pdm09 | 147 |
| HIV | 146 |
| PfSRA | 145 |
| United | 140 |
| HCoV-229E | 140 |
| Dis | 140 |
| B | 139 |
| HKU1 | 139 |
| sha | 134 |
| IFN | 132 |
| Supplementary | 130 |
| CI | 130 |
| Influenza | 129 |
| HI | 128 |
| Coronavirus | 125 |
| sera | 121 |
| States | 118 |
| ELISA | 117 |
| LRT | 114 |
| Vero | 110 |
| IgG | 108 |
| H5N1 | 106 |
| Figure | 106 |
| HA | 104 |
| ILI | 103 |
| B19 | 102 |
| Hong | 101 |
| CoVs | 101 |
| Ebola | 100 |
| EBOV | 100 |
| Institute | 98 |
| DNA | 95 |
| TIV | 95 |
| Kong | 92 |
| Human | 91 |
| Research | 89 |
| University | 88 |
| HAI | 88 |
| East | 88 |
| DC | 87 |
| F | 86 |
| hRSV | 86 |
| II | 86 |
| SFTSV | 84 |
| Africa | 84 |
| ARI | 84 |
| National | 83 |
| NP | 83 |
| World | 81 |
| URT | 81 |
| Diseases | 81 |
| Organization | 80 |
| Disease | 79 |
| Middle | 78 |
| Infectious | 78 |
| HCoVs | 77 |
| FRI | 76 |
| New | 75 |
| NH | 75 |
| NAI | 75 |
| GP | 75 |
| IgM | 74 |
| N | 74 |
| HAdV | 73 |
| ACE2 | 73 |
| parainfluenza | 71 |
| L | 69 |
| TNF | 67 |
| Netherlands | 66 |
| Hospital | 66 |
| US | 65 |
| C. | 65 |
| AIDS | 65 |
| CF | 64 |
| CCR2 | 64 |
| M. | 64 |
| Leishmania | 64 |
| Zika | 62 |
| Singapore | 62 |
| S1 | 62 |
| LDI | 62 |
| Vg9Vd2 | 61 |
| ICU | 60 |
| L. | 60 |
| March | 60 |
| January | 59 |
| m102.4 | 58 |
| FIB-4 | 58 |
| Control | 57 |
| CD8 | 56 |
| Thailand | 55 |
| PARV4 | 55 |
| H7N9 | 55 |
| S. | 54 |
| infdis | 54 |
| G | 53 |
| Nipah | 52 |
| Viral | 51 |
| Center | 51 |
| SIGN | 50 |
| PBS | 50 |
| mg | 49 |
| IL-6 | 49 |
| J. | 48 |
| Japan | 48 |
| Prevention | 48 |
| Wuhan | 48 |
| HCP | 47 |
| CT | 47 |
| West | 46 |
| Mincle | 46 |
| Laboratory | 46 |
| Journal | 46 |
| TCID | 45 |
| April | 45 |
| HMPV | 45 |
| proprotein | 45 |
| ע | 45 |
| IgA | 45 |
| Respiratory | 44 |
| Kawasaki | 44 |
| GenBank | 44 |
| December | 44 |
| CDC | 44 |
| AS03 | 44 |
| P. | 43 |
| LoS | 43 |
| Virus | 43 |
| Qiagen | 43 |
| torovirus | 43 |
| rAd5-S1 | 42 |
| York | 42 |
| R. | 42 |
| HCV | 42 |
| February | 42 |
| FEV | 42 |
| Centers | 42 |
| Plasmodium | 41 |
| HCT | 41 |
| mL | 41 |
| RBD | 41 |
| metapneumovirus | 41 |
| Union | 40 |
| Medical | 39 |
| Fisher | 39 |
| Department | 39 |
| IU | 38 |
| ACEi | 38 |
| A(H1N1 | 38 |
| PPMV-1 | 38 |
| T. | 38 |
| SFTS | 38 |
| MIIV | 37 |
| Kenya | 37 |
| HEV | 37 |
| Detection | 37 |
| Committee | 37 |
| A(H7N9 | 37 |
| E. | 36 |
| International | 36 |
| Invitrogen | 36 |
| α | 35 |
| KD | 35 |
| ICMJE | 35 |
| Form | 35 |
| Disclosure | 35 |
| Canada | 35 |
| Group | 34 |
| Antibody | 34 |
| CoV. | 34 |
| H2N2 | 34 |
| van | 34 |
| SD | 34 |
| WB | 34 |
| IQR | 34 |
| I | 33 |
| Clinical | 33 |
| EVD | 33 |
| A(H5N1 | 33 |
| IFA | 33 |
| IVIG | 33 |
| RTI | 33 |
| October | 32 |
| IL-10 | 32 |
| HSV | 32 |
| Europe | 32 |
| E4 | 32 |
| Dr. | 32 |
| ARB | 32 |
| meta | 32 |
| CPE | 31 |
| E6 | 31 |
| DTS | 31 |
| Li | 31 |
| GDD | 31 |
| Study | 31 |
| Syndrome | 31 |
| Pandemic | 30 |
| PIV | 30 |
| Australia | 30 |
| GOF | 29 |
| DENV | 29 |
| BAL | 29 |
| Roche | 29 |
| Virochip | 29 |
| convertases | 29 |
| sG | 28 |
| remdesivir | 28 |
| oseltamivir | 28 |
| Infection | 28 |
| H. | 28 |
| CMV | 28 |
| A. | 28 |
| D | 27 |
| Applied | 27 |
| Association | 27 |
| CLR | 27 |
| Program | 27 |
| Germany | 27 |
| I. | 27 |
| • | 27 |
| America | 26 |
| August | 26 |
| G. | 26 |
| IDSA | 26 |
| MN | 26 |
| NiV | 26 |
| hMPV | 26 |
| nan | 26 |
| nucleocapsid | 26 |
| ± | 26 |
| DMEM | 25 |
| RANTES | 25 |
| H3N2 | 25 |
| III | 25 |
| Development | 25 |
| mRNA | 25 |
| qPCR | 25 |
| Ϫ/Ϫ | 25 |
| pH | 25 |
| R | 24 |
| Biosystems | 24 |
| D. | 24 |
| H7 | 24 |
| HCWs | 24 |
| NK | 24 |
| Novel | 24 |
| OUD | 24 |
| AKI | 24 |
| Review | 24 |
| September | 24 |
| Sera | 24 |
| VP2 | 24 |
| gd | 24 |
| nucleoprotein | 24 |
| β-1a | 24 |
| SDA | 24 |
| Mann | 23 |
| BD | 23 |
| BMT | 23 |
| Ct | 23 |
| GSK | 23 |
| H2 | 23 |
| SUD | 23 |
| Taiwan | 23 |
| U | 23 |
| V. | 23 |
| der | 23 |
| γ | 23 |
| American | 22 |
| NSABB | 22 |
| Eagle | 22 |
| France | 22 |
| I1314L | 22 |
| MBP | 22 |
| nan | 22 |
| Bangladesh | 22 |
| Province | 22 |
| ROC | 22 |
| Whitney | 22 |
| bocavirus | 22 |
| cruzi | 22 |
| virus | 22 |
| RLR | 22 |
| July | 21 |
| CD3 | 21 |
| FBS | 21 |
| Fig | 21 |
| FluMist | 21 |
| IEIP | 21 |
| IL-1 | 21 |
| May | 21 |
| ORF8s | 21 |
| PRNT | 21 |
| Rochester | 21 |
| Soviet | 21 |
| Use | 21 |
| VL | 21 |
| Laboratories | 20 |
| A/ | 20 |
| Asia | 20 |
| B. | 20 |
| City | 20 |
| E | 20 |
| EMC | 20 |
| K. | 20 |
| Kingdom | 20 |
| TMPRSS2 | 20 |
| MassTag | 20 |
| November | 20 |
| PoCT | 20 |
| S2 | 20 |
| bronchoalveolar | 20 |
| kg | 20 |
| serologic | 20 |
| Δ1313 | 20 |
| NS2 | 20 |
| Immunogenicity | 19 |
| MOI | 19 |
| MIP-1a | 19 |
| MDA5 | 19 |
| Institutional | 19 |
| Bio | 19 |
| GVHD | 19 |
| Evaluation | 19 |
| COPD | 19 |
| NW | 19 |
| Ministry | 19 |
| Prism | 19 |
| P3 | 19 |
| Protein | 19 |
| Republic | 19 |
| Scientific | 19 |
| Supplemental | 19 |
| Tecumseh | 19 |
| Toronto | 19 |
| Vaccine | 19 |
| Wang | 19 |
| merozoite | 19 |
| Care | 18 |
| HAl | 18 |
| H | 18 |
| Global | 18 |
| FluV | 18 |
| Children | 18 |
| African | 18 |
| CFR | 18 |
| CCL2 | 18 |
| C2 | 18 |
| Board | 18 |
| IC | 18 |
| AST | 18 |
| HIV-1 | 18 |
| Animal | 18 |
| Mini | 18 |
| TesT | 18 |
| Mycoplasma | 18 |
| W. | 18 |
| ΔNS2 | 18 |
| Virology | 18 |
| Treatment | 18 |
| vivo | 18 |
| Sigma | 18 |
| Science | 18 |
| Rhinovirus | 18 |
| Patient | 18 |
| P1 | 18 |
| Serologic | 18 |
| IV | 17 |
| MDMs | 17 |
| LRTI | 17 |
| Kit | 17 |
| Immunization | 17 |
| H9N2 | 17 |
| Haven | 17 |
| Flu | 17 |
| Centre | 17 |
| B19V | 17 |
| North | 17 |
| Molecular | 17 |
| QIAamp | 17 |
| Public | 17 |
| bp | 17 |
| SCoV | 17 |
| pLAIV | 17 |
| non | 17 |
| doc_id | 17 |
| siRNA | 17 |
| Zaire | 17 |
| WHO | 17 |
| U.S. | 17 |
| State | 17 |
| June | 16 |
| ABI | 16 |
| All | 16 |
| Assessment | 16 |
| Congo | 16 |
| DPP4 | 16 |
| ETEC | 16 |
| Escherichia | 16 |
| Fas | 16 |
| GraphPad | 16 |
| ADE | 16 |
| K | 16 |
| MSA | 16 |
| Medicine | 16 |
| P | 16 |
| SAS | 16 |
| Syk | 16 |
| VSV | 16 |
| hCoV | 16 |
| X | 16 |
| MRC-5 | 16 |
| David | 15 |
| HRV'X | 15 |
| GMT | 15 |
| FACS | 15 |
| Esper | 15 |
| Epidemiology | 15 |
| Act | 15 |
| DCs | 15 |
| Community | 15 |
| Biosciences | 15 |
| Arabia | 15 |
| IP-10 | 15 |
| ADCC | 15 |
| Healthcare | 15 |
| GM | 15 |
| IPP | 15 |
| SL | 15 |
| sinicus | 15 |
| IgG1 | 15 |
| VE | 15 |
| Trypanosoma | 15 |
| Services | 15 |
| SPSS | 15 |
| Transmission | 15 |
| Rapid | 15 |
| RV | 15 |
| Paul | 15 |
| Latinos | 15 |
| Institutes | 15 |
| Anti | 14 |
| IDU | 14 |
| HPIV | 14 |
| IL-5 | 14 |
| FasL | 14 |
| EFB | 14 |
| CL | 14 |
| Beijing | 14 |
| AFE | 14 |
| Analysis | 14 |
| A[H1N1]pdm09 | 14 |
| ATCC | 14 |
| AS03-adjuvanted | 14 |
| APACHE | 14 |
| A(H3N2 | 14 |
| < | 14 |
| Kaeo | 14 |
| John | 14 |
| a-2b | 14 |
| M1 | 14 |
| USA | 14 |
| ≥40 | 14 |
| NT | 14 |
| paramyxovirus | 14 |
| influenza | 14 |
| ft | 14 |
| antibody | 14 |
| Wantai | 14 |
| perforin | 14 |
| Surveillance | 14 |
| Saudi | 14 |
| Sa | 14 |
| Protection | 14 |
| Pneumonia | 14 |
| ORF8 | 14 |
| Network | 14 |
| Sudan | 14 |
| Dulbecco | 13 |
| Impact | 13 |
| Hoek | 13 |
| Hendra | 13 |
| HeLa | 13 |
| H7N7 | 13 |
| European | 13 |
| CAP | 13 |
| Coronaviridae | 13 |
| CSF | 13 |
| CRP | 13 |
| Biotechnology | 13 |
| Americans | 13 |
| LLC | 13 |
| Italy | 13 |
| Cross | 13 |
| MAARI | 13 |
| ≥65 | 13 |
| MBL-2 | 13 |
| −80 | 13 |
| ϫ | 13 |
| Tris | 13 |
| System | 13 |
| Rousettus | 13 |
| Viruses | 13 |
| Pulmonary | 13 |
| Pathogenesis | 13 |
| NF | 13 |
| N. | 13 |
| Marburg | 13 |
| MCL | 13 |
| Dr | 12 |
| MDCK | 12 |
| Long | 12 |
| LAIV | 12 |
| Korea | 12 |
| Interferon | 12 |
| Identification | 12 |
| F. | 12 |
| EM | 12 |
| C6/36 | 12 |
| Dengue | 12 |
| Democratic | 12 |
| Data | 12 |
| California | 12 |
| CHMP | 12 |
| CA | 12 |
| MOUD | 12 |
| Background | 12 |
| MK2 | 12 |
| MD | 12 |
| MV | 12 |
| W | 12 |
| simplex | 12 |
| Medicaid | 12 |
| pandemic | 12 |
| nAbs | 12 |
| lymphopenia | 12 |
| kB | 12 |
| astrovirus | 12 |
| Y. | 12 |
| figu | 12 |
| Team | 12 |
| PPE | 12 |
| Society | 12 |
| Michael | 12 |
| OligoC | 12 |
| Meta | 12 |
| Pteropus | 12 |
| SDS | 12 |
| College | 11 |
| IFN- | 11 |
| FluSure | 11 |
| Fab | 11 |
| Effectiveness | 11 |
| Infections | 11 |
| Drug | 11 |
| Diagnostics | 11 |
| DRC | 11 |
| Coronaviruses | 11 |
| AEs | 11 |
| Chronic | 11 |
| Cell | 11 |
| C1 | 11 |
| Breda | 11 |
| Advisory | 11 |
| ARD | 11 |
| ANOVA | 11 |
| A2 | 11 |
| LRI | 11 |
| LPH | 11 |
| B4 | 11 |
| MHV | 11 |
| TM | 11 |
| MPV | 11 |
| pH1N1 | 11 |
| monocyte | 11 |
| ic | 11 |
| hyperimmune | 11 |
| Wilcoxon | 11 |
| Vaccines | 11 |
| VBDs | 11 |
| UK | 11 |
| enteroviruses | 11 |
| School | 11 |
| Methods | 11 |
| Rad | 11 |
| Peru | 11 |
| Newcastle | 11 |
| NPIs | 11 |
| Mycobacterium | 11 |
| Millipore | 11 |
| San | 11 |
| IFITM | 10 |
| Ig | 10 |
| Inf | 10 |
| Kaplan | 10 |
| P2 | 10 |
| Meier | 10 |
| ORF1 | 10 |
| Oseltamivir | 10 |
| PAR-2 | 10 |
| HRVA | 10 |
| HSV-2 | 10 |
| 3C | 10 |
| H7N3 | 10 |
| CoV-1 | 10 |
| Chen | 10 |
| Chan | 10 |
| Central | 10 |
| Agency | 10 |
| Adults | 10 |
| Adenovirus | 10 |
| ARC | 10 |
| PPR | 10 |
| 3B | 10 |
| PCI | 10 |
| LTCF | 10 |
| Polymerase | 10 |
| TRAIL | 10 |
| Preparations | 10 |
| ϭ | 10 |
| replicase | 10 |
| rAd5-GFP | 10 |
| kDa | 10 |
| Yang | 10 |
| VAH | 10 |
| Type | 10 |
| Trials | 10 |
| Test | 10 |
| TaqMan | 10 |
| lO | 10 |
| Studies | 10 |
| Rhinolophus | 10 |
| RBA | 10 |
| Seroepidemiologic | 10 |
| RXXR | 10 |
| Response | 10 |
| Regional | 10 |
| Rhinoviruses | 10 |
| Robert | 10 |
| SARI | 10 |
| SIGNR | 10 |
| Efficacy | 9 |
| H7N1 | 9 |
| Emerging | 9 |
| Ethics | 9 |
| Euroimmun | 9 |
| Gibco | 9 |
| Green | 9 |
| H5 | 9 |
| Investigation | 9 |
| HBV | 9 |
| IBV | 9 |
| India | 9 |
| Ivanovsky | 9 |
| Louis | 9 |
| MAVS | 9 |
| DPI | 9 |
| Effect | 9 |
| AUC | 9 |
| DFA | 9 |
| Allergy | 9 |
| MF59 | 9 |
| 18S | 9 |
| 229E. | 9 |
| ALT | 9 |
| APMV-1 | 9 |
| Administration | 9 |
| Assay | 9 |
| CC | 9 |
| BS | 9 |
| Berlin | 9 |
| Biological | 9 |
| Biotech | 9 |
| Bocavirus | 9 |
| CARD9 | 9 |
| MCP-1 | 9 |
| Columbia | 9 |
| MIP-1α | 9 |
| St. | 9 |
| Swiss | 9 |
| Systems | 9 |
| Thermo | 9 |
| Total | 9 |
| Tropical | 9 |
| URTI | 9 |
| Vietnam | 9 |
| Wei | 9 |
| Youden | 9 |
| aegyptiacus | 9 |
| eSensor | 9 |
| hematoxylin | 9 |
| multiorgan | 9 |
| protein | 9 |
| ML | 9 |
| ≈6 | 9 |
| Yale | 9 |
| South | 9 |
| PFT | 9 |
| Scott | 9 |
| Microbiology | 9 |
| Model | 9 |
| N2 | 9 |
| Nile | 9 |
| OD | 9 |
| ORFs | 9 |
| Norway | 9 |
| Promega | 9 |
| RVP | 9 |
| Recovery | 9 |
| Risk | 9 |
| SE | 9 |
| Pfizer | 9 |
| SG05 | 9 |
| HCl | 8 |
| High | 8 |
| Immune | 8 |
| IRB | 8 |
| IL-1b | 8 |
| HIVMA | 8 |
| Helsinki | 8 |
| HR | 8 |
| KZ52 | 8 |
| James | 8 |
| Norwalk | 8 |
| Life | 8 |
| Lim | 8 |
| MAFLD | 8 |
| MX10 | 8 |
| Michigan | 8 |
| N1 | 8 |
| NIH | 8 |
| NPV | 8 |
| OC | 8 |
| Government | 8 |
| Guinea | 8 |
| Ann | 8 |
| GlaxoSmithKline | 8 |
| GPC | 8 |
| -80 | 8 |
| .05 | 8 |
| Aedes | 8 |
| PRK | 8 |
| Antigen | 8 |
| BALB | 8 |
| BJ04 | 8 |
| CBER | 8 |
| Chicago | 8 |
| Collection | 8 |
| Comparative | 8 |
| Convalescent | 8 |
| Council | 8 |
| County | 8 |
| Culture | 8 |
| ELISPOT | 8 |
| Emergency | 8 |
| Foundation | 8 |
| GE | 8 |
| Office | 8 |
| Muench | 8 |
| Patients | 8 |
| occludens-1 | 8 |
| acetyl | 8 |
| anti | 8 |
| antigen | 8 |
| bunyavirus | 8 |
| dithiocarbamate | 8 |
| granzyme | 8 |
| jid | 8 |
| mAbs | 8 |
| nAb | 8 |
| pdm09 | 8 |
| Y | 8 |
| penton | 8 |
| rNa | 8 |
| tachypnea | 8 |
| zanamivir | 8 |
| × | 8 |
| Ϫ1082 | 8 |
| ≈3 | 8 |
| ≥1:40 | 8 |
| Peter | 8 |
| Zhang | 8 |
| mmol | 8 |
| Wong | 8 |
| Safety | 8 |
| Plasma | 8 |
| Van | 8 |
| Project | 8 |
| R39 | 8 |
| Reagent | 8 |
| Reed | 8 |
| SG06 | 8 |
| SPR | 8 |
| SPRs | 8 |
| SCR | 8 |
| Sciences | 8 |
| Student | 8 |
| V | 8 |
| TGEV | 8 |
| Surface | 8 |
| Tg | 8 |
| Spike | 8 |
| Spearman | 8 |
| Southern | 8 |
| H3 | 7 |
| Interference | 7 |
| Guangdong | 7 |
| HCoV. | 7 |
| HRVB | 7 |
| HRVs | 7 |
| Hepatitis | 7 |
| IL-8 | 7 |
| IRP | 7 |
| IgG. | 7 |
| Information | 7 |
| Lung | 7 |
| Jordan | 7 |
| KPNW | 7 |
| Kintampo | 7 |
| Koch | 7 |
| Kwok | 7 |
| LASV | 7 |
| LD | 7 |
| Legionella | 7 |
| Liu | 7 |
| MEGA | 7 |
| GenMark | 7 |
| Gilead | 7 |
| Aerosol | 7 |
| Fluviral | 7 |
| Fc | 7 |
| Maria | 7 |
| 3D | 7 |
| Age | 7 |
| Amersham | 7 |
| Associated | 7 |
| BW | 7 |
| Bank | 7 |
| Benjamin | 7 |
| Bhatt | 7 |
| Biologicals | 7 |
| Booth | 7 |
| CD40L | 7 |
| CMI | 7 |
| CXR | 7 |
| Cancer | 7 |
| Chain | 7 |
| EBV | 7 |
| ESR | 7 |
| Egypt | 7 |
| Endo | 7 |
| FVC | 7 |
| Malaysia | 7 |
| TLR3 | 7 |
| Martin | 7 |
| copies/10 | 7 |
| Toll | 7 |
| Vibrio | 7 |
| Victoria | 7 |
| Vincent | 7 |
| WNV | 7 |
| Wallis | 7 |
| Wu | 7 |
| Yu | 7 |
| amantadine | 7 |
| association | 7 |
| coronaviruses | 7 |
| Survey | 7 |
| endosomal | 7 |
| eosin | 7 |
| gammadelta | 7 |
| henipavirus | 7 |
| hpi | 7 |
| m101 | 7 |
| pyrrolidine | 7 |
| thrombocytopenia | 7 |
| ≥2 | 7 |
| Materials | 7 |
| Time | 7 |
| glycophorin | 7 |
| NOP | 7 |
| PAGE | 7 |
| NIAID | 7 |
| MedImmune | 7 |
| NL | 7 |
| NL/579/2003 | 7 |
| NS | 7 |
| NTSs | 7 |
| Northern | 7 |
| Nunc | 7 |
| OR | 7 |
| Novartis | 7 |
| Parvoviridae | 7 |
| Region | 7 |
| Sepsis-3 | 7 |
| Sendai | 7 |
| Seattle | 7 |
| Parvovirus | 7 |
| SWH | 7 |
| RNeasy | 7 |
| Programme | 7 |
| Practices | 7 |
| Stata | 7 |
| HongKong/156/97 | 6 |
| Host | 6 |
| Histopathological | 6 |
| HEp-2 | 6 |
| Histologic | 6 |
| Herpes | 6 |
| Hemisphere | 6 |
| HLA | 6 |
| Malaria | 6 |
| HCoV-229E. | 6 |
| George | 6 |
| GP2 | 6 |
| Fred | 6 |
| Francisco | 6 |
| First | 6 |
| IMLD50/0.015 | 6 |
| Facility | 6 |
| Hubei | 6 |
| Ka | 6 |
| IgG2b | 6 |
| Illumina | 6 |
| Eyal | 6 |
| Madin | 6 |
| Macaca | 6 |
| Lee | 6 |
| Ks | 6 |
| Kruskal | 6 |
| Keywords | 6 |
| KHDSS | 6 |
| Jonathan | 6 |
| Joint | 6 |
| Jennifer | 6 |
| Isolation | 6 |
| Interim | 6 |
| Inhibitor | 6 |
| Inc. | 6 |
| Fabs | 6 |
| Beckman | 6 |
| Epidemiologic | 6 |
| CJIP | 6 |
| CD40 | 6 |
| CCR5 | 6 |
| Barr | 6 |
| Baltimore | 6 |
| Australian | 6 |
| Assays | 6 |
| Ankara | 6 |
| Angiotensin | 6 |
| Alexander | 6 |
| Accra | 6 |
| ATP | 6 |
| AIC | 6 |
| ACE | 6 |
| -6 | 6 |
| Mexico | 6 |
| CIs | 6 |
| CLEC5A | 6 |
| Enzyme | 6 |
| Charles | 6 |
| Environment | 6 |
| England | 6 |
| Edinburgh | 6 |
| EDTA | 6 |
| Duke | 6 |
| Drs | 6 |
| Diagnosis | 6 |
| Defense | 6 |
| Declaration | 6 |
| Darby | 6 |
| Coxsackie | 6 |
| Copan | 6 |
| Cochrane | 6 |
| Cluster | 6 |
| Chemicon | 6 |
| Melbourne | 6 |
| Andrew | 6 |
| Monto | 6 |
| WI-38 | 6 |
| Zeiss | 6 |
| Yersinia | 6 |
| Yamagata | 6 |
| Xiao | 6 |
| XX | 6 |
| White | 6 |
| Washington | 6 |
| WBC | 6 |
| Thomas | 6 |
| Virologic | 6 |
| Virginia | 6 |
| Vgamma9Vdelta2 | 6 |
| VP1 | 6 |
| VBD | 6 |
| UA | 6 |
| Tukey | 6 |
| aa | 6 |
| coryza | 6 |
| coxsackievirus | 6 |
| disease | 6 |
| Moscow | 6 |
| schizont | 6 |
| rNP | 6 |
| prednisone | 6 |
| pneumovirus | 6 |
| nonsepsis | 6 |
| mm | 6 |
| mL. | 6 |
| lavage | 6 |
| lamblia | 6 |
| herpes | 6 |
| globulin | 6 |
| encephalomyocarditis | 6 |
| ebola | 6 |
| donovani | 6 |
| Torovirus | 6 |
| east | 6 |
| Technologies | 6 |
| PCM4 | 6 |
| Parker | 6 |
| Park | 6 |
| PRISMA | 6 |
| PRISM | 6 |
| PPV | 6 |
| PID | 6 |
| PE | 6 |
| One | 6 |
| People | 6 |
| ORF2 | 6 |
| Neuraminidase | 6 |
| Navrongo | 6 |
| Nations | 6 |
| NPAs | 6 |
| NORC | 6 |
| Tang | 6 |
| Pearson | 6 |
| PCM3 | 6 |
| QIAGEN | 6 |
| ST | 6 |
| TX | 6 |
| TBK1 | 6 |
| Quebec | 6 |
| Sweden | 6 |
| Structure | 6 |
| StataCorp | 6 |
| Serum | 6 |
| Statistics | 6 |
| Resources | 6 |
| Report | 6 |
| Reference | 6 |
| RbCV | 6 |
| Richard | 6 |
| RDP | 6 |
| R&D | 6 |
| Humoral | 5 |
| Hutchinson | 5 |
| H1 | 5 |
| H9N2-infected | 5 |
| HPIV-1 | 5 |
| Histopathologic | 5 |
| Haemophilus | 5 |
| Ho | 5 |
| Hui | 5 |
| Guangxi | 5 |
| Guatemala | 5 |
| FW | 5 |
| Gregory | 5 |
| Good | 5 |
| Ghana | 5 |
| Gene | 5 |
| Food | 5 |
| FDA | 5 |
| Epstein | 5 |
| Epidemiological | 5 |
| IL-2 | 5 |
| El | 5 |
| ID | 5 |
| MERS- | 5 |
| IL-4 | 5 |
| Ltd | 5 |
| EMC/2012 | 5 |
| Metapneumovirus | 5 |
| Memorial | 5 |
| Massachusetts | 5 |
| Mark | 5 |
| Manitoba | 5 |
| MLD | 5 |
| MA | 5 |
| M2 | 5 |
| Luminex | 5 |
| LoS. | 5 |
| ILAS | 5 |
| Lin | 5 |
| Leung | 5 |
| Lassa | 5 |
| LPV | 5 |
| KDH | 5 |
| Joseph | 5 |
| JID | 5 |
| Islands | 5 |
| IgG2a | 5 |
| Ian | 5 |
| Eastern | 5 |
| Antibodies | 5 |
| Drosten | 5 |
| Anthony | 5 |
| Brian | 5 |
| Blood | 5 |
| Black | 5 |
| Betacoronavirus | 5 |
| Bcl-2 | 5 |
| Axl | 5 |
| Austria | 5 |
| Atlanta | 5 |
| Armed | 5 |
| Monocyte | 5 |
| Anderson | 5 |
| CD27 | 5 |
| Amlexanox | 5 |
| Americas | 5 |
| Acute | 5 |
| Abbott | 5 |
| Ab | 5 |
| AU | 5 |
| AL | 5 |
| 3A | 5 |
| 2C | 5 |
| /CD38 | 5 |
| CD107a | 5 |
| CD56 | 5 |
| Division | 5 |
| Chinese | 5 |
| District | 5 |
| Discovery | 5 |
| Diamond | 5 |
| DAT | 5 |
| Cytomegalovirus | 5 |
| Cryptosporidiosis | 5 |
| Consortium | 5 |
| Comprehensive | 5 |
| Christopher | 5 |
| Chlamydia | 5 |
| Cheng | 5 |
| CD8(+ | 5 |
| Characteristics | 5 |
| Cameroon | 5 |
| Calif | 5 |
| Caco-2 | 5 |
| CPK | 5 |
| COVID-2019 | 5 |
| COVID | 5 |
| CMA | 5 |
| CLDSI | 5 |
| CDCD | 5 |
| Miller | 5 |
| Furin | 5 |
| Mountain | 5 |
| WV | 5 |
| betacoronavirus | 5 |
| Z. | 5 |
| Yuen | 5 |
| Yi | 5 |
| Yan | 5 |
| Xu | 5 |
| Working | 5 |
| Western | 5 |
| Wendy | 5 |
| Welfare | 5 |
| VP4 | 5 |
| calnexin | 5 |
| VLP | 5 |
| Triton | 5 |
| Tor2 | 5 |
| Theresa | 5 |
| Therapy | 5 |
| Text | 5 |
| Tests | 5 |
| Taqman | 5 |
| Tables | 5 |
| TTV | 5 |
| cDNA | 5 |
| cytomegalovirus | 5 |
| TIM-1 | 5 |
| po | 5 |
| N95 | 5 |
| ≥4-fold | 5 |
| ≥ | 5 |
| ϩ | 5 |
| vol | 5 |
| turkey | 5 |
| transmembrane | 5 |
| rotaviruses | 5 |
| rhinorrhea | 5 |
| quadruplicate | 5 |
| nonendemic | 5 |
| ddPCR | 5 |
| myocyte | 5 |
| ml | 5 |
| medRxiv | 5 |
| jejuni | 5 |
| interferon | 5 |
| immunoblot | 5 |
| ij | 5 |
| ie | 5 |
| iADE | 5 |
| hepatitis | 5 |
| TTSH | 5 |
| nonintegrin | 5 |
| Station | 5 |
| Ontario | 5 |
| Post | 5 |
| Population | 5 |
| Performance | 5 |
| Peiris | 5 |
| Patrick | 5 |
| Pathogens | 5 |
| Pathogen | 5 |
| Panel | 5 |
| Pan | 5 |
| PIV3 | 5 |
| Oligo | 5 |
| Pseudomonas | 5 |
| Okinawa | 5 |
| OI | 5 |
| OC38 | 5 |
| O. | 5 |
| NUS | 5 |
| NPI | 5 |
| NPC-1 | 5 |
| NHP | 5 |
| Spectrum | 5 |
| NC | 5 |
| Princess | 5 |
| Nigeria | 5 |
| Py | 5 |
| Renwick | 5 |
| Severe | 5 |
| Q | 5 |
| Sino | 5 |
| Seroprevalence | 5 |
| Seroepidemiology | 5 |
| SNP | 5 |
| SG11 | 5 |
| SG09 | 5 |
| SAEs | 5 |
| Rhesus | 5 |
| Sarna | 5 |
| RPMI | 5 |
| Recombinant | 5 |
| Receptor | 5 |
| Real | 5 |
| RdRp | 5 |
| Queensland | 5 |
| RTV | 5 |
| RESTV | 5 |
| RNAseP | 5 |
| Registry | 5 |
| GEO | 4 |
| GGO | 4 |
| Guillain | 4 |
| GA | 4 |
| Fry | 4 |
| Frederick | 4 |
| Frankfurt | 4 |
| GP1 | 4 |
| Genetics | 4 |
| GPI | 4 |
| Gamaleya | 4 |
| Geneva | 4 |
| Genome | 4 |
| Genomic | 4 |
| German | 4 |
| Fouchier | 4 |
| Giardia | 4 |
| Frank | 4 |
| Evan | 4 |
| Forces | 4 |
| Force | 4 |
| ELISARS | 4 |
| HRP | 4 |
| EU | 4 |
| Ebolavirus | 4 |
| Education | 4 |
| Emergence | 4 |
| England/727/06 | 4 |
| Epidemic | 4 |
| Erdman | 4 |
| Ethiopia | 4 |
| Excel | 4 |
| Expression | 4 |
| F1R1 | 4 |
| F1R2 | 4 |
| F3R1 | 4 |
| Falsey | 4 |
| Fluorescent | 4 |
| HB29 | 4 |
| Jim | 4 |
| Harderian | 4 |
| HeV | 4 |
| Jeffrey | 4 |
| KDM5 | 4 |
| KDM5B | 4 |
| KRIBB | 4 |
| Kaiser | 4 |
| Katherine | 4 |
| Kelly | 4 |
| Kenneth | 4 |
| Kilifi | 4 |
| Kim | 4 |
| LT | 4 |
| Lamson | 4 |
| Lasergene | 4 |
| Latin | 4 |
| Le | 4 |
| Lei | 4 |
| EBA-175 | 4 |
| Jean | 4 |
| Janssen | 4 |
| Jan | 4 |
| IL-12p40 | 4 |
| Healthy | 4 |
| Henipavirus | 4 |
| Hyperimmune | 4 |
| Hypertension | 4 |
| IBM | 4 |
| IC50 | 4 |
| IL | 4 |
| IRR | 4 |
| Jackson | 4 |
| ISH | 4 |
| Illness | 4 |
| Immunology | 4 |
| Incidence | 4 |
| Inhibition | 4 |
| Initiative | 4 |
| Israel | 4 |
| ECMO | 4 |
| Authority | 4 |
| Dutch | 4 |
| Biosafety | 4 |
| Alaska | 4 |
| Albright | 4 |
| Aldrich | 4 |
| Ambion | 4 |
| Amsterdam | 4 |
| Analyzer | 4 |
| Anne | 4 |
| Antigenic | 4 |
| Arabian | 4 |
| Associates | 4 |
| BCoV | 4 |
| BEI | 4 |
| BRL | 4 |
| BSA | 4 |
| Berne | 4 |
| BigDye | 4 |
| Biology | 4 |
| Alan | 4 |
| Akaike | 4 |
| Affordable | 4 |
| ACIP | 4 |
| LightCycler | 4 |
| 1C | 4 |
| 229E | 4 |
| 2c | 4 |
| 3E | 4 |
| A(H2N2 | 4 |
| A(H7N7 | 4 |
| AG | 4 |
| Affairs | 4 |
| AP-1 | 4 |
| APS | 4 |
| ARV | 4 |
| Abcam | 4 |
| Adam | 4 |
| Addiction | 4 |
| Adolescent | 4 |
| Biomedical | 4 |
| Bonaphton | 4 |
| Doremalen | 4 |
| Branch | 4 |
| Clustal | 4 |
| Co. | 4 |
| CoV2A | 4 |
| Common | 4 |
| Comparison | 4 |
| Core | 4 |
| Coulter | 4 |
| Cov | 4 |
| Cox | 4 |
| Cryptosporidia | 4 |
| Cryptosporidium | 4 |
| Côte | 4 |
| DHF | 4 |
| DIFA | 4 |
| DSA | 4 |
| Dean | 4 |
| Dong | 4 |
| Christian | 4 |
| Chlamydophila | 4 |
| Chiu | 4 |
| CD19 | 4 |
| Bristol | 4 |
| British | 4 |
| Bronchoalveolar | 4 |
| Brook | 4 |
| C6 | 4 |
| CCL5 | 4 |
| CD16 | 4 |
| CLL | 4 |
| Chandipura | 4 |
| CNS | 4 |
| CO | 4 |
| CR6261 | 4 |
| CTM | 4 |
| CXCL10 | 4 |
| Calbiochem | 4 |
| Carl | 4 |
| Leningrad | 4 |
| Roswell | 4 |
| Lvov | 4 |
| d'Ivoire | 4 |
| Veterans | 4 |
| Vgamma2Vdelta2 | 4 |
| Victorian | 4 |
| Vienna | 4 |
| WSN/33(H1N1 | 4 |
| William | 4 |
| Wisconsin | 4 |
| Women | 4 |
| XXXX | 4 |
| Yao | 4 |
| Zhao | 4 |
| aOR | 4 |
| analysis | 4 |
| baculovirus | 4 |
| biopsy | 4 |
| brucei | 4 |
| committee | 4 |
| VI | 4 |
| VH | 4 |
| VERO | 4 |
| Technology | 4 |
| THP-1 | 4 |
| TSB | 4 |
| Tam | 4 |
| Tan | 4 |
| Taq | 4 |
| Task | 4 |
| Taxonomy | 4 |
| Texas | 4 |
| URI | 4 |
| Thai | 4 |
| Tokyo | 4 |
| Training | 4 |
| Tree | 4 |
| Trial | 4 |
| Trypsin | 4 |
| Tween | 4 |
| copathogens | 4 |
| den | 4 |
| TCID50 | 4 |
| dodecyl | 4 |
| surface | 4 |
| transwell | 4 |
| type | 4 |
| unadjuvanted | 4 |
| villous | 4 |
| wash | 4 |
| zonula | 4 |
| µNT | 4 |
| β | 4 |
| κB | 4 |
| μL | 4 |
| Ϫ | 4 |
| ∼50 | 4 |
| ≤ | 4 |
| ≥3 | 4 |
| ≥37.5 | 4 |
| MAFFT | 4 |
| rhinovirus | 4 |
| rhesus | 4 |
| review | 4 |
| hPPMV-1 | 4 |
| endotheliitis | 4 |
| enterocolitica | 4 |
| enterotoxigenic | 4 |
| genomic | 4 |
| genotype | 4 |
| gi30027610 | 4 |
| h. | 4 |
| histolytica | 4 |
| preimmune | 4 |
| inactivator | 4 |
| key | 4 |
| kinetics | 4 |
| malaria | 4 |
| myxovirus | 4 |
| novo | 4 |
| paraformaldehyde | 4 |
| TDR | 4 |
| virologic | 4 |
| Systematic | 4 |
| Poly | 4 |
| NICU | 4 |
| NIID | 4 |
| NY | 4 |
| NaCl | 4 |
| Nagel | 4 |
| Natural | 4 |
| Niemann | 4 |
| Normandy | 4 |
| OC43-immune | 4 |
| Odisha | 4 |
| PBSϪ | 4 |
| PCM1 | 4 |
| Pathology | 4 |
| Pediatric | 4 |
| Peninsula | 4 |
| Pershin | 4 |
| PfSUB-1 | 4 |
| N3 | 4 |
| N1-N3 | 4 |
| Myanmar | 4 |
| Man | 4 |
| MERSpp | 4 |
| Sydney | 4 |
| MF59-adjuvanted | 4 |
| MGB-3 | 4 |
| MGI | 4 |
| MLPA | 4 |
| MMAD | 4 |
| Mary | 4 |
| Muthuri | 4 |
| Maryland | 4 |
| Material | 4 |
| Maternal | 4 |
| Merck | 4 |
| Microarray | 4 |
| Microsoft | 4 |
| Ming | 4 |
| Pleural | 4 |
| Ma | 4 |
| Practice | 4 |
| SG10 | 4 |
| SOT | 4 |
| SSP | 4 |
| SYBR | 4 |
| Sentinel | 4 |
| Sequence | 4 |
| Shigella | 4 |
| Smith | 4 |
| Spain | 4 |
| Special | 4 |
| Specimen | 4 |
| Staphylococcus | 4 |
| Star | 4 |
| Stony | 4 |
| Strip | 4 |
| Super | 4 |
| Preferred | 4 |
| Subjects | 4 |
| SGH | 4 |
| Steven | 4 |
| SG03 | 4 |
| Reston | 4 |
| RAxML | 4 |
| SG01 | 4 |
| RU | 4 |
| R0 | 4 |
| QIAquick | 4 |
| RdRpSeq | 4 |
| Red | 4 |
| Replication | 4 |
| Randomized | 4 |
| Reverse | 4 |
| Rocky | 4 |
| ␥ | 4 |
| SFCs/ | 4 |
| Rvachev | 4 |
| SA | 4 |
| SCRs | 4 |
| Heart | 3 |
| Holland | 3 |
| Hill | 3 |
| Henan | 3 |
| Hematopoietic | 3 |
| Heinz | 3 |
| Habitat | 3 |
| Hayden | 3 |
| HEPES | 3 |
| HKU5 | 3 |
| HKU1-specifi | 3 |
| HEVORF1-S1 | 3 |
| HEVORF1-A1 | 3 |
| HEL | 3 |
| Holloway | 3 |
| Hunan | 3 |
| Home | 3 |
| ICUs | 3 |
| IMPAACT | 3 |
| IL-1α | 3 |
| HBoV. | 3 |
| IL-17 | 3 |
| IKKε | 3 |
| IFAs | 3 |
| ICAM-3 | 3 |
| Hopkins | 3 |
| IAV | 3 |
| Hung | 3 |
| Huang | 3 |
| Hsiung | 3 |
| HotStar | 3 |
| Hospitalized | 3 |
| HEF | 3 |
| Galegov | 3 |
| HAdVs | 3 |
| Fitzgerald | 3 |
| Fund | 3 |
| Function | 3 |
| Fujian | 3 |
| Francis | 3 |
| Forest | 3 |
| FlowJo | 3 |
| Finnzymes | 3 |
| Gag | 3 |
| FilmArray | 3 |
| Ferret | 3 |
| Ferguson | 3 |
| Feldmann | 3 |
| IgGs | 3 |
| Fast | 3 |
| GMM | 3 |
| Gal | 3 |
| HAV | 3 |
| Growth | 3 |
| H9N2- | 3 |
| H1N1-and | 3 |
| H1N1- | 3 |
| Gump | 3 |
| Guangzhou | 3 |
| Guang | 3 |
| Groups | 3 |
| Gao | 3 |
| Graham | 3 |
| Giemsa | 3 |
| Ghendon | 3 |
| Genotype | 3 |
| Genetic | 3 |
| General | 3 |
| IPD | 3 |
| Lu | 3 |
| Immobilon | 3 |
| MEM | 3 |
| MacConkey | 3 |
| Mabtech | 3 |
| MVA | 3 |
| MSP1 | 3 |
| MLV | 3 |
| MIV | 3 |
| MBL | 3 |
| Lightcycler | 3 |
| MAFM | 3 |
| MAALRI | 3 |
| M1-specific | 3 |
| M.-J. | 3 |
| Luis | 3 |
| Low | 3 |
| MagNA | 3 |
| Makona | 3 |
| Malik | 3 |
| Manual | 3 |
| Marion | 3 |
| Master | 3 |
| Matlab | 3 |
| Matthias | 3 |
| McIntosh | 3 |
| Md | 3 |
| MeSH | 3 |
| Median | 3 |
| Medicinal | 3 |
| Medicines | 3 |
| Mediterranean | 3 |
| Meng | 3 |
| Familial | 3 |
| Lipkin | 3 |
| Liang | 3 |
| Immunocompromised | 3 |
| Intranasal | 3 |
| Jones | 3 |
| Jonas | 3 |
| Jie | 3 |
| Jason | 3 |
| Involvement | 3 |
| Intravenous | 3 |
| Integrated | 3 |
| Lia | 3 |
| Insufficiency | 3 |
| Induction | 3 |
| Inc | 3 |
| InDRE4487/2009 | 3 |
| Immunotech | 3 |
| Immunospot | 3 |
| Joshua | 3 |
| K+ | 3 |
| K-12 | 3 |
| K560A | 3 |
| Kallestad | 3 |
| Kang | 3 |
| Karen | 3 |
| Kaye | 3 |
| Ken | 3 |
| LC | 3 |
| La | 3 |
| Lancet | 3 |
| Lane | 3 |
| Laurent | 3 |
| Leone | 3 |
| Level | 3 |
| Lewis | 3 |
| Fang | 3 |
| CTL | 3 |
| False | 3 |
| Blueprint | 3 |
| BrdU | 3 |
| Borrelia | 3 |
| Borna | 3 |
| Bonferroni | 3 |
| Boeckh | 3 |
| BoV | 3 |
| Bishop | 3 |
| Basic | 3 |
| Bioscience | 3 |
| Biolabs | 3 |
| Bernard | 3 |
| Belgium | 3 |
| Becton | 3 |
| Beck | 3 |
| Burden | 3 |
| CA07 | 3 |
| CAN97 | 3 |
| CD14 | 3 |
| CD40-targeted | 3 |
| CD40L. | 3 |
| CKD | 3 |
| COVID19 | 3 |
| MgCl | 3 |
| Ca | 3 |
| California/07/09 | 3 |
| Campbell | 3 |
| Campylobacter | 3 |
| Candida | 3 |
| Candidate | 3 |
| Capacity | 3 |
| Cardiac | 3 |
| Baxter | 3 |
| Based | 3 |
| Case | 3 |
| ACTT | 3 |
| Adjuvant | 3 |
| Academies | 3 |
| Abt | 3 |
| A[H1N1 | 3 |
| ARDS | 3 |
| API | 3 |
| ACEi/ | 3 |
| Barbara | 3 |
| A59 | 3 |
| 8) | 3 |
| 2E | 3 |
| 2D | 3 |
| 138ЊC | 3 |
| -3 | 3 |
| Advanced | 3 |
| Air | 3 |
| Al | 3 |
| Albert | 3 |
| Alicia | 3 |
| Alignment | 3 |
| Animals | 3 |
| Antigenicity | 3 |
| Antonio | 3 |
| Application | 3 |
| Approach | 3 |
| Arbor/6/60 | 3 |
| Architect | 3 |
| Avian | 3 |
| B7 | 3 |
| BACKGROUND | 3 |
| BamHI | 3 |
| Carolina | 3 |
| Caspian | 3 |
| FTLS | 3 |
| EC | 3 |
| Early | 3 |
| ERV | 3 |
| EPIC | 3 |
| EMEM | 3 |
| EIA | 3 |
| EFBs | 3 |
| Donald | 3 |
| Diagnostic | 3 |
| Diversity | 3 |
| Directors | 3 |
| Dipeptidyl | 3 |
| Ding | 3 |
| Differential | 3 |
| Diego | 3 |
| Ecology | 3 |
| Elden | 3 |
| Engineering | 3 |
| Enterotoxigenic | 3 |
| Environmental | 3 |
| Epredict | 3 |
| Erasmus | 3 |
| Eric | 3 |
| Erythrocyte | 3 |
| Eugene | 3 |
| Exacerbations | 3 |
| Experimental | 3 |
| F2R1 | 3 |
| FDR | 3 |
| FLUA | 3 |
| FMLP | 3 |
| FRI-1 | 3 |
| Dickinson | 3 |
| Denka | 3 |
| CatL | 3 |
| CoV-2-specific | 3 |
| Contribution | 3 |
| Contamination | 3 |
| Congress | 3 |
| Collaboration | 3 |
| Cold | 3 |
| Cohort | 3 |
| Clinic | 3 |
| Dectin-2 | 3 |
| Clara | 3 |
| Civil | 3 |
| Chu | 3 |
| Chemokine | 3 |
| Characterisation | 3 |
| Chagas | 3 |
| Cooperation | 3 |
| Coronative | 3 |
| Corp. | 3 |
| Covid-19 | 3 |
| Cowling | 3 |
| Coxsackievirus | 3 |
| Cryptococcus | 3 |
| CsCl | 3 |
| Cycle | 3 |
| Cytotoxicity | 3 |
| D12 | 3 |
| DBA/2 | 3 |
| DNase | 3 |
| Dako | 3 |
| Daniel | 3 |
| De | 3 |
| Deborah | 3 |
| Metagenomic | 3 |
| CCR2-deficient | 3 |
| Min | 3 |
| WIV1 | 3 |
| XL | 3 |
| X. | 3 |
| Windows | 3 |
| Williams | 3 |
| Willey | 3 |
| Ward | 3 |
| Virgin | 3 |
| Xie | 3 |
| Victor | 3 |
| Veterinary | 3 |
| Veronique | 3 |
| VLPs | 3 |
| VAERD | 3 |
| VA | 3 |
| XR | 3 |
| Yanfeng | 3 |
| Stability | 3 |
| agar | 3 |
| board | 3 |
| avidity | 3 |
| appendix | 3 |
| antemortem | 3 |
| and/ | 3 |
| allantoic | 3 |
| actin | 3 |
| Yolken | 3 |
| Zlydnikov | 3 |
| Zhongnan | 3 |
| Zhejiang | 3 |
| Zealand | 3 |
| Yunnan | 3 |
| Yung | 3 |
| V5 | 3 |
| Urisman | 3 |
| Universal | 3 |
| Superscript | 3 |
| TIVprimed | 3 |
| T7 | 3 |
| T2DM | 3 |
| Sør | 3 |
| Syncytial | 3 |
| Support | 3 |
| SuperScript | 3 |
| Univariate | 3 |
| Sun | 3 |
| Subtype | 3 |
| Su | 3 |
| Stephen | 3 |
| Step | 3 |
| Stations | 3 |
| TOPO | 3 |
| TPH | 3 |
| TRIzol | 3 |
| TT | 3 |
| TVC | 3 |
| Tao | 3 |
| Thierry | 3 |
| Thoracic | 3 |
| Titers | 3 |
| Tool | 3 |
| Tor3 | 3 |
| Tor7 | 3 |
| Treanor | 3 |
| Trøndelag | 3 |
| U. | 3 |
| UNDP | 3 |
| Ujvári | 3 |
| bronchiolitis | 3 |
| chymotrypsin | 3 |
| convalescent | 3 |
| picornavirus | 3 |
| salmonellae | 3 |
| rRT | 3 |
| rRNA | 3 |
| qRTPCR | 3 |
| postvaccination | 3 |
| pigeon | 3 |
| phosphoantigen | 3 |
| microscopy | 3 |
| peruviana | 3 |
| patient | 3 |
| parasitemia | 3 |
| parainfluenzavirus | 3 |
| nonresearch | 3 |
| ng | 3 |
| series | 3 |
| sialodacryoadenitis | 3 |
| titer | 3 |
| trypomastigotes | 3 |
| virome | 3 |
| virus-2 | 3 |
| von | 3 |
| ward | 3 |
| ±12 | 3 |
| Ϫ308 | 3 |
| Ϫ592 | 3 |
| р2 | 3 |
| −20 | 3 |
| ≤2 | 3 |
| ≥1 | 3 |
| ≥10 | 3 |
| Minnesota | 3 |
| monovalent | 3 |
| messenger | 3 |
| convertase | 3 |
| flavivirus | 3 |
| health | 3 |
| hPRSS | 3 |
| hPPMV-1/ | 3 |
| group | 3 |
| grey | 3 |
| furin | 3 |
| ferrumequinum | 3 |
| mAb | 3 |
| ferret | 3 |
| fascicularis | 3 |
| far | 3 |
| falciparum | 3 |
| cpe | 3 |
| coronavirus | 3 |
| hemophagocytosis | 3 |
| heterologous | 3 |
| heterotypic | 3 |
| hexon | 3 |
| hilum | 3 |
| histopathological | 3 |
| human | 3 |
| ii | 3 |
| iii | 3 |
| infantum | 3 |
| inflammasome | 3 |
| inocula | 3 |
| intracerebral | 3 |
| leukonychia | 3 |
| livia | 3 |
| lung | 3 |
| lysates | 3 |
| Standard | 3 |
| extrapulmonary | 3 |
| St | 3 |
| Pathogenic | 3 |
| Permanente | 3 |
| Pel | 3 |
| Pediatrics | 3 |
| Peak | 3 |
| Pavia | 3 |
| Paulo | 3 |
| Pasteur | 3 |
| PfAMA-1 | 3 |
| Paramyxovirus | 3 |
| Pacific | 3 |
| PUMC | 3 |
| PROSPERO | 3 |
| PRIDE | 3 |
| PR | 3 |
| Persistence | 3 |
| PfRH5 | 3 |
| Protective | 3 |
| Poisson | 3 |
| Professor | 3 |
| Products | 3 |
| Prince | 3 |
| Preventive | 3 |
| President | 3 |
| Potential | 3 |
| Pneumocystis | 3 |
| Pharmacia | 3 |
| Plex | 3 |
| Ping | 3 |
| Picornavirus | 3 |
| Pick | 3 |
| Philippines | 3 |
| Philip | 3 |
| PNGase | 3 |
| PN | 3 |
| PIV2 | 3 |
| NJ | 3 |
| Nasopharyngeal | 3 |
| Nancy | 3 |
| NUH | 3 |
| NTX | 3 |
| NS-1 | 3 |
| NPA | 3 |
| NIBSC | 3 |
| PFU | 3 |
| NHS | 3 |
| NCBI | 3 |
| Monique | 3 |
| Mix | 3 |
| Spencer | 3 |
| Missouri | 3 |
| Ng | 3 |
| Nguyen | 3 |
| Ni | 3 |
| NiV. | 3 |
| Nickbakhsh | 3 |
| Non | 3 |
| ORF6 | 3 |
| Olavs | 3 |
| OneStep | 3 |
| Opioid | 3 |
| PAA | 3 |
| PALM | 3 |
| PAN | 3 |
| PBL | 3 |
| PCM2 | 3 |
| PEF | 3 |
| PER.C6 | 3 |
| Protease | 3 |
| PMNLs/ | 3 |
| Proteolytic | 3 |
| Sandra | 3 |
| Seasonal | 3 |
| Sea | 3 |
| Script | 3 |
| Scotland | 3 |
| Schistosoma | 3 |
| Sanitary | 3 |
| Salmonella | 3 |
| Seg | 3 |
| Saliva | 3 |
| SUPPORT | 3 |
| STL43 | 3 |
| ST2 | 3 |
| SR | 3 |
| SNA | 3 |
| Seeplex | 3 |
| Seiken | 3 |
| SG07 | 3 |
| Simmonds | 3 |
| Specimens | 3 |
| Species | 3 |
| Protocol | 3 |
| Southeast | 3 |
| Software | 3 |
| Smorodintsev | 3 |
| Sierra | 3 |
| Semiquantitative | 3 |
| Shi | 3 |
| Shenzhen | 3 |
| Sheng | 3 |
| Serology | 3 |
| Serological | 3 |
| Senegal | 3 |
| SIRT1 | 3 |
| Secondary | 3 |
| R406 | 3 |
| Qpid | 3 |
| Rachel | 3 |
| RV15 | 3 |
| RNase | 3 |
| RCV | 3 |
| RAT | 3 |
| Quality | 3 |
| Qiu | 3 |
| Ren | 3 |
| Qin | 3 |
| QIAmp | 3 |
| Pure | 3 |
| PubMed | 3 |
| SG04 | 3 |
| Puerto | 3 |
| Recommendations | 3 |
| Rabbit | 3 |
| Royal | 3 |
| Rnest | 3 |
| S2b | 3 |
| S.-C. | 3 |
| Rural | 3 |
| Renal | 3 |
| Rockville | 3 |
| River | 3 |
| Ribavirin | 3 |
| Reynolds | 3 |
| Reviews | 3 |
| Renin | 3 |
| SFCs/2 | 3 |
| SCID | 3 |
| Honglin | 2 |
| Hospitalization | 2 |
| Hoogen | 2 |
| Histopathology | 2 |
| Homozygous | 2 |
| Hoffmann | 2 |
| Hu | 2 |
| House | 2 |
| Hangzhou | 2 |
| Hughes | 2 |
| Huh7 | 2 |
| Humans | 2 |
| Hygiene | 2 |
| ICS | 2 |
| IEM | 2 |
| Hideki | 2 |
| IFN)- | 2 |
| Histopaque-1077 | 2 |
| Hao | 2 |
| HiTrap | 2 |
| Hexaplex | 2 |
| IFNβ-1a | 2 |
| Hannah | 2 |
| Hans | 2 |
| Hancock | 2 |
| Hartog | 2 |
| Hashem | 2 |
| Hawaii | 2 |
| Heartland | 2 |
| Heat | 2 |
| Hedman | 2 |
| Helper | 2 |
| Hemadsorption | 2 |
| Henrik | 2 |
| HepG2 | 2 |
| Heterosubtypic | 2 |
| IFNs | 2 |
| Innovative | 2 |
| IIV | 2 |
| Increases | 2 |
| Indian | 2 |
| Indiana | 2 |
| Individual | 2 |
| Indonesia/05/2005 | 2 |
| Infants | 2 |
| Infectivity | 2 |
| Infektionen | 2 |
| Inhibitors | 2 |
| Inhibitory | 2 |
| Innate | 2 |
| Inocula | 2 |
| Institut | 2 |
| Instruments | 2 |
| Hamburg | 2 |
| Insurance | 2 |
| Index | 2 |
| Immunosuppression | 2 |
| IL)-6 | 2 |
| Immunoreactive | 2 |
| IL-13 | 2 |
| IL-1β | 2 |
| IL-21 | 2 |
| IMLD | 2 |
| INS | 2 |
| IRRs | 2 |
| IRS | 2 |
| ISARIC | 2 |
| ITMA | 2 |
| Idaho | 2 |
| IgM+ | 2 |
| Immunity | 2 |
| Immuno | 2 |
| Immunodominant | 2 |
| Immunoglobulin | 2 |
| Hammitt | 2 |
| Fusion | 2 |
| Hall | 2 |
| Gel | 2 |
| Gallucci | 2 |
| Galveston | 2 |
| Gammadelta | 2 |
| Gammagard | 2 |
| Gandhi | 2 |
| Gardens | 2 |
| Gary | 2 |
| Genbank | 2 |
| Haenzel | 2 |
| GeneScan | 2 |
| Generation | 2 |
| Georgia | 2 |
| Gert | 2 |
| Glaxo | 2 |
| Glo | 2 |
| GlutaMAX | 2 |
| Galanti | 2 |
| Gaithersburg | 2 |
| Gabon | 2 |
| GZ | 2 |
| Intramural | 2 |
| Florian | 2 |
| Florida | 2 |
| Frances | 2 |
| Freund | 2 |
| Fruit | 2 |
| Fung | 2 |
| G439A | 2 |
| GAA | 2 |
| GCG | 2 |
| GISAID | 2 |
| GMFR | 2 |
| GNA | 2 |
| GNL | 2 |
| GTR | 2 |
| Gnirß | 2 |
| Gold | 2 |
| Golubev | 2 |
| HBoVspecific | 2 |
| HCW | 2 |
| HCoV-229 | 2 |
| HECV | 2 |
| HKU4 | 2 |
| HNFV | 2 |
| HOS | 2 |
| HPA | 2 |
| HPIV-2 | 2 |
| HPIV-3 | 2 |
| HPIV-4 | 2 |
| HPIVs | 2 |
| HRV'X'-2 | 2 |
| HRV-1b | 2 |
| HVR | 2 |
| Haematological | 2 |
| HC0 | 2 |
| HBSS | 2 |
| Gordon | 2 |
| HAT1 | 2 |
| Grace | 2 |
| Greene | 2 |
| Greenhow | 2 |
| Greninger | 2 |
| Guan | 2 |
| Guideline | 2 |
| Guidelines | 2 |
| Guo | 2 |
| H1N1pdm09 | 2 |
| H1N1v | 2 |
| H292 | 2 |
| H3K4me1 | 2 |
| H4A3 | 2 |
| H5N1-infected | 2 |
| H7N2 | 2 |
| Intracellular | 2 |
| Mei | 2 |
| InvivoGen | 2 |
| MEGA5 | 2 |
| Luke | 2 |
| Lv | 2 |
| Lynch | 2 |
| Lys | 2 |
| M13 | 2 |
| MAE | 2 |
| MAbs | 2 |
| MFI | 2 |
| Mackay | 2 |
| MICA | 2 |
| MMP | 2 |
| MPH | 2 |
| MRC5 | 2 |
| MSD | 2 |
| MTT | 2 |
| Macherey | 2 |
| Luciferase | 2 |
| Luan | 2 |
| Ltd. | 2 |
| Louise | 2 |
| Leibniz | 2 |
| Leibovitz | 2 |
| Leong | 2 |
| Letter | 2 |
| Leukonychia | 2 |
| Light | 2 |
| Likert | 2 |
| Lima | 2 |
| Linden | 2 |
| Ling | 2 |
| Lipofectamine | 2 |
| Liquid | 2 |
| Liver | 2 |
| Lonza | 2 |
| Lorraine | 2 |
| Machery | 2 |
| Mainstreaming | 2 |
| Isabelle | 2 |
| Miltenyi | 2 |
| Meeting | 2 |
| Mega | 2 |
| Fischer | 2 |
| Metaanalysis | 2 |
| MiSeq | 2 |
| Michel | 2 |
| Middleton | 2 |
| Ministries | 2 |
| Major | 2 |
| Mission/1918 | 2 |
| Mo | 2 |
| Monoclonal | 2 |
| Monovalent | 2 |
| Montull | 2 |
| Morphogenesis | 2 |
| Mortality | 2 |
| Medline | 2 |
| Medium | 2 |
| Measurement | 2 |
| McNemar | 2 |
| Malinee | 2 |
| Manager | 2 |
| Manning | 2 |
| Mantel | 2 |
| Marc | 2 |
| Marcel | 2 |
| Marco | 2 |
| Marie | 2 |
| Masayuki | 2 |
| Mass | 2 |
| Matteo | 2 |
| Maximum | 2 |
| Maxisorp | 2 |
| Mayinga | 2 |
| McCaustland | 2 |
| Lectin | 2 |
| Laura | 2 |
| Lau | 2 |
| K99 | 2 |
| José | 2 |
| Julia | 2 |
| Julian | 2 |
| Jun | 2 |
| Jung | 2 |
| Jurkat | 2 |
| K443A | 2 |
| K99-specific | 2 |
| Larry | 2 |
| KKH | 2 |
| KNPRC | 2 |
| KPL | 2 |
| Kamchatka | 2 |
| Kanta | 2 |
| Karin | 2 |
| Karl | 2 |
| Josine | 2 |
| Johnston | 2 |
| Johns | 2 |
| Joe | 2 |
| Items | 2 |
| Ivory | 2 |
| Jamie | 2 |
| Jane | 2 |
| Janine | 2 |
| Jenny | 2 |
| Jens | 2 |
| Jerome | 2 |
| Jerry | 2 |
| Jerusalem | 2 |
| Jiang | 2 |
| Jiangsu | 2 |
| Jin | 2 |
| Jing | 2 |
| Jo | 2 |
| Karolinska | 2 |
| Karron | 2 |
| Katharine | 2 |
| Kristin | 2 |
| Kuiken | 2 |
| Kurihara | 2 |
| Kuypers | 2 |
| Kärber | 2 |
| L15 | 2 |
| L32 | 2 |
| LP | 2 |
| LRIs | 2 |
| LSRT | 2 |
| Labor | 2 |
| Lack | 2 |
| Lai | 2 |
| Laird | 2 |
| Lake | 2 |
| Lam | 2 |
| Kryptosporidien | 2 |
| Kreuznach | 2 |
| Kazuko | 2 |
| Koopmans | 2 |
| Kazunori | 2 |
| Keith | 2 |
| Kelvin | 2 |
| Kerstin | 2 |
| Kevin | 2 |
| Khalili | 2 |
| Kikwit | 2 |
| Kilianski | 2 |
| Kimberly | 2 |
| Kinetics | 2 |
| Kinetoplastida | 2 |
| Kistler | 2 |
| Klaus | 2 |
| Kluwer | 2 |
| Koh | 2 |
| Florence | 2 |
| Chi | 2 |
| Financial | 2 |
| Bell | 2 |
| Barry | 2 |
| Barré | 2 |
| Bartels | 2 |
| BatCoV | 2 |
| Bedford | 2 |
| Beek | 2 |
| Behring | 2 |
| Benoit | 2 |
| Biofire | 2 |
| Big | 2 |
| Billerica | 2 |
| Bilthoven | 2 |
| BioConcept | 2 |
| BioEdit | 2 |
| BioLife | 2 |
| BioMérieux | 2 |
| Barre | 2 |
| Barney | 2 |
| Bao | 2 |
| Bangkok | 2 |
| Ayouba | 2 |